COMMUNIQUÉS West-GlobeNewswire

Recro Pharma Reports Second Quarter 2018 Financial Results
07/08/2018
Company to Host Conference Call Today at 8:00 AM ET MALVERN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the [...]
Kamada Reports Financial Results for Second Quarter and First Six Months of 2018
07/08/2018
Total Revenues for Second Quarter were $33.8 Million, a 4% Increase Over Second Quarter of 2017 Total Revenues for First Half of 2018 were $51.3 Million, a 16% Increase Over First Half of 2017 Gross Profit for First [...]
Amicus Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Updates
07/08/2018
2Q18 Net Product Sales of $21.3M Driven by Galafold ® (Migalastat) Expansion Company Increases FY18 Global Galafold Revenue Guidance to $80M-$90M Pompe Clinical, Regulatory and Manufacturing Activities Continue to [...]
MediWound Reports Second Quarter 2018 Financial Results
07/08/2018
Completion of enrollment of Phase 3 DETECT Study of NexoBrid ® Strategic discussions advancing with multiple parties Conference call begins today at 8:30 a.m. Eastern Time YAVNE, Israel, Aug. 07, 2018 (GLOBE NEWSWIRE [...]
Desert Medical Imaging Chooses CLS Mobile Laser & Non-Cooled Fiber for Clinical Trial of MRI-Guided Focal Laser Therapy for Prostate Cancer
07/08/2018
FRAMINGHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc . (CLS Americas), a subsidiary of CLS AB in Lund, Sweden, today announced its TRANBERG® Thermal Therapy System will be [...]
Cara Therapeutics Doses First Patient in Second Pivotal Phase 3 Efficacy Trial of KORSUVA™ (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus
07/08/2018
KALM™-2 trial to evaluate the efficacy of KORSUVA™ injection at 12 weeks STAMFORD, Conn., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and [...]
Madrigal Pharmaceuticals Reports 2018 Second Quarter Financial Results and Reviews Key Clinical Achievements
07/08/2018
Madrigal’s MGL-3196 NASH abstract selected for oral presentation in the presidential plenary clinical session of The Liver Meeting® 2018 during the American Association for the Study of Liver Diseases 2018 Annual [...]
PRA Health Sciences, Inc. Announces Pricing of Secondary Offering of 6,500,000 Shares of Common Stock
07/08/2018
RALEIGH, N.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced the pricing of the previously announced secondary offering of shares of its common stock. An [...]
ImmuCell Hires Senior Director of Quality
07/08/2018
PORTLAND, Maine, Aug. 07, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Dentsply Sirona Reports Second Quarter 2018 Results
07/08/2018
Reported Q2 revenues of $1,042.1 million, up 5.0% compared to prior year; constant currency growth 1 of 1.3% Q2 2018 GAAP EPS of ($4.98) with Q2 2018 non-GAAP adjusted EPS of $0.60 Updated 2018 guidance: non-GAAP [...]
Vical Reports Second Quarter 2018 Financial and Operational Results
07/08/2018
SAN DIEGO, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months ended June 30, 2018. Net loss for the second quarter of 2018 was $4.9 million, or $0.22 [...]
AnaptysBio Announces Second Quarter 2018 Financial Results and Provides Pipeline Updates
07/08/2018
Top-line Phase 2a Data from Etokimab (ANB020) in Eosinophilic Asthma Expected in Third Quarter of 2018 Etokimab Clinical Development Program Expanded to Include Chronic Rhinosinusitis with Nasal Polyps Commercial [...]
ChromaDex and Watsons Expand TRU NIAGEN® Retail Partnership Through 2021
07/08/2018
Global partnership commits to significant growth of TRU NIAGEN® including launch in Turkey IRVINE, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical [...]
Nightstar Therapeutics to Present at Wedbush PacGrow Healthcare Conference
07/08/2018
WALTHAM, Mass. and LONDON, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ: NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced [...]
Invitation: Terveystalo Half Year result audiocast and conference call on 17 August 2018
07/08/2018
Terveystalo Plc will publish its Half Year report for 2018 on Friday, 17 August 2018 at approximately 9:00 am EEST. The company will host an audiocast and conference call in English on17 August at 12:30 Finnish time ( [...]
BioCryst Reports Second Quarter 2018 Financial Results
07/08/2018
RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today financial results for the second quarter ended June 30, 2018. “Building on the clear direction [...]
Fennec Pharmaceuticals Receives Positive Opinion on the Pediatric Investigation Plan From European Medicines Agency for PEDMARK(TM) and Confirmation of Eligibility for a Pediatric Use Marketing Authorization
07/08/2018
RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announced that the Pediatric Committee (PDCO) of the [...]
Shire plc : Director/PDMR Shareholding
07/08/2018
Director/PDMR Shareholding August 7, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging [...]
G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference on August 14, 2018
07/08/2018
RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Medical Officer Raj Malik, M.D., will present a company [...]

Pages